Nl-Fr

View abstract

This abstract is assigned to sessions
Presentation preference Poster and Rapid fire
TitlePembrolizumab and Nivolumab-induced ocular complications: a case report with literature review
Purposeto demonstrates the ocular side effects in a patient receiving Pembrolizumab and Nivolumab for metastatic ovarian cancer
Methodsa case report with brief literature review
ResultsA 37-year-old female with recurrent metastatic ovarian cancer presented with blurred vision (OU) 1 month after receiving Pembrolizumab. Ocular examinations revealed a best-corrected visual acuity (BCVA) of 0.4/0.2 using Landolt C chart, bilateral fine keratic precipitates, cells in the anterior chamber, iris cysts, and macular mottling. Optical coherence tomography indicated outer retinal destruction and visual field reported peripheral defects and an enlarged blind spot. Her BCVA recovered to 0.9/0.7 and the anterior chamber cells and iris cysts subsided with topical prednisolone and cycloplegics for 2 weeks. However, the fundus appearance persisted despite ceasing the immunotherapy. She suffered from similar episodes after receiving Pembrolizumab and Nivolumab one year later, and even developed multiple subretinal fluid (SRF) demonstrating strong staining with mild leakage over the lesions on fluorescein angiography. Oral and topical steroids could cease anterior chamber reactions while SRF only subsided after discontinuation of Pembrolizumab and Nivolumab. Extensive outer retina destruction remained the same without obvious vision improvements.
ConclusionThis case report demonstrates that Pembrolizumab and Nivolumab-related ocular side effects can include bilateral anterior uveitis, iris cysts, and outer retinal destruction. This is also the first case report revealing nearly symmetric retinopathy after the immunotherapy.
Conflict of interestNo
Author 1
Last nameCHO
Initials of first name(s)WH
DepartmentOphthalmology
CityKaohsiung
CountryTaiwan
Author 2
Last nameKuo
Initials of first name(s)HK
DepartmentOphthalmology
CityKaohsiung
CountryTaiwan
Author 3
Last nameChiang
Initials of first name(s)WY
DepartmentOphthalmology
CityKaohsiung
CountryTaiwan